Morgan Stanley’s Fidelity Blue Chip Value ETF FBCV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.79M Buy
145,295
+89,046
+158% +$3.42M ﹤0.01% 4126
2026
Q1
$2.02M Sell
56,249
-9,895
-15% -$365K ﹤0.01% 4760
2025
Q4
$2.36M Buy
66,144
+7,966
+14% +$279K ﹤0.01% 4691
2025
Q3
$1.98M Buy
58,178
+32,190
+124% +$1.08M ﹤0.01% 4795
2025
Q2
$851K Buy
25,988
+15,209
+141% +$481K ﹤0.01% 5189
2025
Q1
$345K Buy
10,779
+6,647
+161% +$213K ﹤0.01% 5501
2024
Q4
$131K Buy
4,132
+92
+2% +$3.02K ﹤0.01% 5950
2024
Q3
$132K Buy
4,040
+3,939
+3,900% +$124K ﹤0.01% 5889
2024
Q2
$3.03K Hold
101
﹤0.01% 6978
2024
Q1
$3.17K Sell
101
-79
-44% -$2.34K ﹤0.01% 6993
2023
Q4
$5.25K Hold
180
﹤0.01% 6825
2023
Q3
$4.95K Sell
180
-15
-8% -$424 ﹤0.01% 6918
2023
Q2
$5.44K Sell
195
-365
-65% -$10.1K ﹤0.01% 6969
2023
Q1
$15.3K Hold
560
﹤0.01% 6730
2022
Q4
$15.8K Sell
560
-455
-45% -$12.6K ﹤0.01% 6774
2022
Q3
$26K Sell
1,015
-90
-8% -$2.48K ﹤0.01% 6673
2022
Q2
$30K Buy
+1,105
New +$31.2K ﹤0.01% 6833

Other funds holding FBCV

Morgan Stanley's FBCV Position: Q2 2026 in Review

Morgan Stanley increased its Fidelity Blue Chip Value ETF (FBCV) stake by 158% in Q2 2026, buying an estimated $3.42M and bringing the position to 145,295 shares worth $5.79M. The position accounts for ﹤0.01% of the portfolio, ranked #4126.

Morgan Stanley first reported a position in FBCV in Q2 2022 and has held it in 17 quarters since. 40 funds tracked by Wall St. Rank hold FBCV as of Q2 2026.

  • Morgan Stanley held 145,295 shares of Fidelity Blue Chip Value ETF worth $5.79M as of Q2 2026.
  • Morgan Stanley bought 89,046 Fidelity Blue Chip Value ETF shares in Q2 2026, an estimated $3.42M.
  • Fidelity Blue Chip Value ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4126 holding.
  • Morgan Stanley first reported a position in Fidelity Blue Chip Value ETF in Q2 2022 and has held it in 17 quarters since.
  • 40 funds tracked by Wall St. Rank held Fidelity Blue Chip Value ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.